Delivery Order SPE2DB22D6029-SPE2DB23FU1NL
Award Date 8/14/23
Potential Completion Date 8/15/23
Potential Value $789
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,819.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561696498 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The place of performance is Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to provide the specified medication for use in supporting Department of Defense health programs. Amerisourcebergen will perform as the prime contractor, with work beginning on...
- The Defense Logistics Agency awarded a $789 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561935252 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The place of performance is Conshohocken, Pennsylvania. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. No set-aside designation or subcontractors are indicated. This order supports DLA's mission to provide logistics...
- The Defense Logistics Agency awarded a $789 delivery order to Amerisourcebergen Drug Corporation for 4562187604 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle and will provide pharmaceutical products to the DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance spans from September 15 to September 18, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $2,197 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561800158 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from August 14 to August 15, 2023. No set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,262 to Amerisourcebergen Drug Corporation for the product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 20, 2023 through September 21, 2023. As the Defense Logistics Agency is the Department of Defense's combat logistics support agency, this delivery order was...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,630 to Amerisourcebergen Drug Corporation for 4562179229 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a period of performance from September 14, 2023 through September 15, 2023 for delivery to a location in Conshohocken, Pennsylvania. As the DLA supports procurement for the Department of Defense, this order is likely associated with the agency's medical supply chain and will deliver the specified...
- The Defense Logistics Agency awarded a $3,260.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561620934 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The order is to be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order supports the DLA's mission to provide logistics support for all military services and...
- The Defense Logistics Agency awarded a $526,000 delivery order to Amerisourcebergen Drug Corporation for the product "MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML." The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceuticals and medical supplies in support of Department of Defense programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 12 to September 13, 2023. The...
- The Defense Logistics Agency awarded a $513 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561558137 MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The order is placed against an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense's medical material needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on July 21, 2023. The fixed-price order advances the DLA's mission to...
- The Defense Logistics Agency awarded a $7,465 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562102722 MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The order was issued against an undisclosed contract vehicle to fulfill a requirement for pharmaceutical products. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania, spanning from September 8 to September 11, 2023. No subcontractors or set aside designations were indicated....
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB23FU1NLDelivery Order
The Defense Logistics Agency awarded a $789 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561798575 MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a single product to be delivered between August 14-15, 2023. As the DLA supports Department of Defense procurement and supply chain needs, this order is likely associated with the agency's pharmaceutical prime vendor program and will supply medication to military treatment facilities within the program's network. No subcontractors or set aside designations were indicated.
Generated 12/17/23, 7:28 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $789 | 8/14/23 |